DCGN is nearing the end of the road: <a href="http://finance.yahoo.com/news/deCODE-genetics-Announces-prnews-14804935.html" rel="nofollow" target="_blank">http://finance.yahoo.com/news/deCODE-genetics-Announces-prnews-14804935.html</a> At December 31, 2008, the company had liquid funds available for operating activities, comprised of cash and cash equivalents together with current investments, of $3.7 million, compared to $64.2 million at December 31, 2007. In early 2009, the company sold its auction rate securities (ARS) for $11.0 million in cash which the company has been using to finance its operating activities. The company believes it has <b>sufficient resources to sustain operations only into the second quarter of this year</b>. It’s already the second quarter.